"Using PhenMap, an AI tool that integrates complex data on the genetic makeup of the tumour, researchers tracked patterns of patient reactions to the drug. This allowed them to identify a group of patients with the same gene mutation who were at high risk of negative reactions."
"Bowel cancer has the second highest mortality rate of any cancer, with survival rates as high as 98% when caught early, but only 10% for advanced cases."
Researchers developed an AI-driven method to predict responses to a new NHS drug for advanced bowel cancer. This approach aims to prevent thousands from receiving ineffective treatments. Advanced bowel cancer has a high mortality rate, with survival rates dropping significantly once the disease progresses. The study involved 117 patients treated with chemotherapy and bevacizumab, which is effective for a limited group and has serious side effects. The AI tool, PhenMap, analyzes genetic data to identify patient responses and risks, with hopes to expand its application to other cancers.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]